Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Drugs|January 17, 2008
Gut hormones as potential new targets for appetite regulation and the treatment of obesityBenjamin C T Field, Alison M Wren, Dunstan Cooke, et al.Nuclear Medicine Communications|November 20, 2023
Radioactive iodine treatment for Graves' hyperthyroidism: incidence of Graves orbitopathyNicole Q X Quah, Manvi M Sobti, Alison M Wren, et al.Neuroendocrinology|November 29, 2002
The hypothalamic mechanisms of the hypophysiotropic action of ghrelinAlison M Wren, Caroline J Small, Charlotte V Fribbens, et al.The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trialNicola M Neary, Caroline J Small, Alison M Wren, et al.Endocrinology|August 23, 2003
Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormoneCaroline R Abbott, Adam R Kennedy, Alison M Wren, et al.Diabetes|July 28, 2005
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trialKatie Wynne, Adrian J Park, Caroline J Small, et al.Diabetes|April 2, 2010
PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humansBenjamin C T Field, Alison M Wren, Veronique Peters, et al.Kidney International|April 24, 2009
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatmentDamien R Ashby, Heather E Ford, Katie J Wynne, et al.Nature|August 9, 2002
Gut hormone PYY(3-36) physiologically inhibits food intakeRachel L Batterham, Michael A Cowley, Caroline J Small, et al.Pageof 1